X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
post-endoscopic retrograde cholangiopancreatography pancreatitis (62) 62
gastroenterology & hepatology (52) 52
humans (45) 45
endoscopic retrograde cholangiopancreatography (43) 43
complications (40) 40
index medicus (40) 40
cholangiopancreatography, endoscopic retrograde - adverse effects (38) 38
pancreatitis (35) 35
pancreatitis - etiology (28) 28
male (27) 27
ercp pancreatitis (26) 26
female (26) 26
pancreatitis - prevention & control (25) 25
treatment outcome (25) 25
risk factors (23) 23
aged (21) 21
middle aged (21) 21
risk-factors (21) 21
sphincterotomy (20) 20
prevention (19) 19
surgical procedures, operative (18) 18
post-ercp pancreatitis (16) 16
digestive system diseases (15) 15
metaanalysis (15) 15
prospective multicenter (15) 15
retrograde (14) 14
stents (14) 14
pancreatitis - diagnosis (13) 13
digestive system (12) 12
meta-analysis (12) 12
rectal indomethacin (12) 12
adult (11) 11
endoscopy (11) 11
pancreatitis - epidemiology (11) 11
post‐endoscopic retrograde cholangiopancreatography pancreatitis (11) 11
surgery (11) 11
cholangiopancreatography, endoscopic retrograde - instrumentation (10) 10
cholangiopancreatography, endoscopic retrograde - methods (10) 10
management (10) 10
retrospective studies (10) 10
therapeutic ercp (10) 10
acute disease (9) 9
acute pancreatitis (9) 9
aged, 80 and over (9) 9
multicenter (9) 9
nonsteroidal anti-inflammatory drugs (9) 9
prospective studies (9) 9
retrospective study (9) 9
stent placement (9) 9
biliary sphincterotomy (8) 8
diclofenac (8) 8
education (8) 8
endoscopic (8) 8
randomized controlled trial (8) 8
risk (8) 8
time factors (8) 8
analysis (7) 7
bile (7) 7
cardiovascular system (7) 7
catheters (7) 7
indomethacin (7) 7
medicine, general & internal (7) 7
mortality (7) 7
pancreas (7) 7
placement (7) 7
post-endoscopic retrograde cholangiopancreatography (7) 7
randomized controlled trials as topic (7) 7
randomized controlled-trial (7) 7
risk factor (7) 7
somatostatin (7) 7
stent (7) 7
administration, rectal (6) 6
anti-inflammatory agents, non-steroidal - administration & dosage (6) 6
bile-duct cannulation (6) 6
double-blind (6) 6
ercp (6) 6
gabexate mesylate (6) 6
high-risk patients (6) 6
hyperamylasemia (6) 6
pain (6) 6
pancreatic ducts - surgery (6) 6
post endoscopic retrograde cholangiopancreatography pancreatitis (6) 6
prophylaxis (6) 6
造影 (6) 6
abdomen (5) 5
amylases (5) 5
anti-inflammatory agents, non-steroidal - therapeutic use (5) 5
bile-duct (5) 5
common bile-duct (5) 5
controlled-trial (5) 5
drainage - adverse effects (5) 5
endoscopic sphincterotomy (5) 5
health aspects (5) 5
incidence (5) 5
non-steroidal anti-inflammatory drugs (5) 5
odds ratio (5) 5
original (5) 5
pancreatic duct stent (5) 5
placebo-controlled trial (5) 5
post-endoscopic (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
世界胃肠病学杂志:英文版(电子版), ISSN 1007-9327, 2014, Volume 20, Issue 29, pp. 10151 - 10157
Journal Article
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2016, Volume 22, Issue 21, pp. 5114 - 5121
AIM: To determine the efficacy of rectally administered naproxen for the prevention of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP).METHODS... 
Naproxen;Nonsteroidal | injection;Post-endoscopic | c | retrograde | drugs;Pancreatic | anti-inflammatory | duct | Pancreatic duct injection | Post-endoscopic retrograde cholangiopancreatography | Nonsteroidal anti-inflammatory drugs | Naproxen | Serum amylase | Pancreatitis | MULTICENTER | RISK-FACTORS | METAANALYSIS | CLINICAL-TRIAL | RECTAL INDOMETHACIN | PREVENTION | GABEXATE MESYLATE | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | COMPLICATIONS | GASTROENTEROLOGY & HEPATOLOGY | ERCP PANCREATITIS | Up-Regulation | Abdominal Pain - prevention & control | Amylases - blood | Hyperamylasemia - prevention & control | Suppositories | Pancreatitis - etiology | Humans | Middle Aged | Cholangiopancreatography, Endoscopic Retrograde - adverse effects | Administration, Rectal | Male | Pancreatitis - prevention & control | Pancreatitis - mortality | Iran | Time Factors | Cholangiopancreatography, Endoscopic Retrograde - mortality | Naproxen - administration & dosage | Adult | Female | Odds Ratio | Naproxen - adverse effects | Severity of Illness Index | Abdominal Pain - etiology | Double-Blind Method | Drug Administration Schedule | Risk Factors | Treatment Outcome | Biomarkers - blood | Chi-Square Distribution | Pancreatitis - diagnosis | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Hyperamylasemia - etiology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Hyperamylasemia - diagnosis | Randomized Controlled Trial
Journal Article
World journal of gastrointestinal endoscopy, ISSN 1948-5190, 10/2018, Volume 10, Issue 10, pp. 259 - 266
.... With the increased need for invasive techniques to treat pancreatic and bile duct pathologies such as endoscopic retrograde cholangiopancreatography (ERCP... 
Minireviews | Endoscopic retrograde cholangiopancreatography | Post endoscopic retrograde cholangiopancreatography pancreatitis | Acute pancreatitis
Journal Article
Journal Article
Journal Article
Journal Article